scispace - formally typeset
B

Bernard Fisher

Researcher at University of Pittsburgh

Publications -  379
Citations -  70162

Bernard Fisher is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 108, co-authored 377 publications receiving 67479 citations. Previous affiliations of Bernard Fisher include University of Texas Health Science Center at San Antonio & Mercy Medical Center (Baltimore, Maryland).

Papers
More filters
Journal ArticleDOI

The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer: Results from NSABP Clinical Trials

TL;DR: In this paper, the authors explored the prognostic significance of preoperative carcinoembryonic antigen (CEA) levels in patients with colorectal cancer and found that preoperative CEA level correlated with the degree of lumen encirclement by tumor.
Journal ArticleDOI

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). I. Observations concerning the multicentricity of mammary cancer

TL;DR: An attempt to correlate the occurrence of multicentric cancers with a large number of pathologic and some clinical features disclosed a statistically significant association between multicentricity and grossly nonencapsulated dominant cancers with maximum diameters greater than 5 cm, the presence of a moderate or marked intraductal component and noninvasive cancer in its vicinity, and tumor involvement of the nipple.
Journal ArticleDOI

Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer.

TL;DR: Multivariate analyses disclosed that both age and tumor differentiation are associated with the ER status, and considered a possible explanation for the dichotomy of response to adjuvant chemotherapy observed in pre and postmenopausal women.
Journal ArticleDOI

Experimental Evidence in Support of the Dormant Tumor Cell

TL;DR: If rats were subjected to repeated laparotomy and liver examination at 7-day intervals 3 months after injection, 100 percent had a tumor within a few weeks.
Journal ArticleDOI

The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials.

TL;DR: The results indicate that the definition of prognostic factors can identify patient subsets with unique characteristics and underscored the role of tumor location and obstruction as prognostic discriminants.